Companies/US/DNA

GINKGO BIOWORKS HOLDINGS, INC.

Income flow

Annual
DNA 10-K Income StatementPeriod 2025-12-31Source 10-K
Cell Engineering Revenue$133MServices & other$37MRevenue$170M-25% Y/YGross profit$139M-27% Y/YCost of revenue$32M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · USD
By activity
By activity$133M
  • Cell Engineering Revenue$133M100.0%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0Shares outTotal shares currently outstanding (issued and not retired).55.4MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).49.9M
Stock splits
  1. 1:402024-08-20